Mediterranean Journal of Rheumatology最新文献_第10页

Soft Tissue Sarcomas Mimicking Benign Inflammatory Processes: A Diagnostic Dilemma. 模仿良性炎症过程的软组织肉瘤：诊断难题。

Mediterranean Journal of Rheumatology Pub Date : 2023-08-27 eCollection Date: 2023-12-01 DOI: 10.31138/mjr.270823.sts

Cleofina Furtado, Rania Zeitoun, Jonathan Wilkes, Vaiyapuri Sumathi, George Tony

{"title":"Soft Tissue Sarcomas Mimicking Benign Inflammatory Processes: A Diagnostic Dilemma.","authors":"Cleofina Furtado, Rania Zeitoun, Jonathan Wilkes, Vaiyapuri Sumathi, George Tony","doi":"10.31138/mjr.270823.sts","DOIUrl":"10.31138/mjr.270823.sts","url":null,"abstract":"Background: Soft tissue sarcomas are rare and often go undetected until a later stage, particularly when they present as intra-articular or tenosynovial lesions mimicking benign synovial pathologies. The failure to distinguish between malignant and benign synovial disease can have a significant impact on patient outcomes and limit alternatives for local control surgery and limb salvage.Case description: In this case series, we present two cases of soft tissue sarcomas, one being an intraarticular synovial chondrosarcoma, and the other a pleomorphic spindle cell sarcoma centred along tendon sheaths. Radiologically, the initial clinical presentation of these cases resembled benign synovial pathologies, leading to a delay in diagnosis and treatment.Conclusion: Our study underscores the importance of maintaining a low threshold of suspicion for surveillance, a multidisciplinary approach, and early histological diagnosis to ensure appropriate timely treatment and a favourable prognosis for patients with soft tissue sarcomas.","PeriodicalId":32816,"journal":{"name":"Mediterranean Journal of Rheumatology","volume":"34 4","pages":"531-536"},"PeriodicalIF":0.0,"publicationDate":"2023-08-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10815534/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139572504","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Comparison of Risk Factors During First and Second Wave of COVID-19 in Patients with Autoimmune Rheumatic Diseases (AIRD): Results from KRACC Subset. 自身免疫性类风湿性疾病（AIRD）患者第一波和第二波新冠肺炎期间危险因素的比较：KRACC亚组的结果。

Mediterranean Journal of Rheumatology Pub Date : 2023-08-27 eCollection Date: 2023-09-01 DOI: 10.31138/mjr.20230827.co

Vikramraj Jain, Vineeta Shobha, Sharath Kumar, Ramya Janardana, Sumithra Selvam

{"title":"Comparison of Risk Factors During First and Second Wave of COVID-19 in Patients with Autoimmune Rheumatic Diseases (AIRD): Results from KRACC Subset.","authors":"Vikramraj Jain, Vineeta Shobha, Sharath Kumar, Ramya Janardana, Sumithra Selvam","doi":"10.31138/mjr.20230827.co","DOIUrl":"10.31138/mjr.20230827.co","url":null,"abstract":"Background: The differential influence and outcome of various risk factors on occurrence of COVID-19 among patients with autoimmune rheumatic diseases (AIRD) during different COVID-19 peaks is underreported.Aim: To assess the impact and outcome of conventional risk factors, immunosuppressants, and comorbidities on the risk of COVID-19 among AIRD patients during the first two COVID-19 peaks.Design: Prospective, non-interventional longitudinal cohort study.Methods: This is a subset of the KRA COVID19 cohort undertaken during the initial wave of COVID-19 (W1) (Apr-Dec2021); and the 2nd-wave (W2) (Jan-Aug2021). Data collected included description of AIRD subsets, treatment characteristics, comorbidities, and COVID-19 occurrence. Risk factors associated with mortality were analysed. The incidence rate was compared with that of the general population in the same geographic region.Results: AIRD patients (n=2969) had a higher incidence of COVID-19 in the W2 (7.1%) than in the W1 (1.7%) as compared to the general population (Government bulletin). Age (p<0.01) and duration of AIRD (p<0.001) influenced COVID-19 occurrence in W2 while major disease subsets and immunosuppressants including glucocorticoids did not. The W2 had lower HCQ usage (Adjusted Odds Ratio [AOR]-0.81) and comorbidities like hypertension (AOR -0.54) and pre-existing lung disease (AOR -0.38;0.19-0.75) compared to W1. Older age (1.11) and coexistent diabetes mellitus (AOR 6.74) were independent risk factors associated with mortality in W2.Conclusions: We report 1.7 times higher occurrence, and no influence of major disease subsets or immunosuppressants including glucocorticoids on COVID-19. Age and diabetes were independent risk factors for mortality.","PeriodicalId":32816,"journal":{"name":"Mediterranean Journal of Rheumatology","volume":"34 3","pages":"342-348"},"PeriodicalIF":0.0,"publicationDate":"2023-08-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10628883/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71522798","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Factors Influencing Liver Abnormalities in Psoriatic Arthritis Patients: A Comprehensive Study. 影响银屑病关节炎患者肝脏异常的因素：一项综合研究

Mediterranean Journal of Rheumatology Pub Date : 2023-08-27 eCollection Date: 2024-06-01 DOI: 10.31138/mjr.050723.fla

Ping Seung Ong, Lay Kim Tan, Hasnah Mat, Najjah Tohar, Abdul Muhaimin Fathi, Nia Maslia Atiera Kosenin, Muhammad Najmi Budiman Naim, Rafiqah Farhanah Redzuan, Nur Iffah Ab Rani, Najiha Arrissa Norhisham, Wahinuddin Sulaiman

{"title":"Factors Influencing Liver Abnormalities in Psoriatic Arthritis Patients: A Comprehensive Study.","authors":"Ping Seung Ong, Lay Kim Tan, Hasnah Mat, Najjah Tohar, Abdul Muhaimin Fathi, Nia Maslia Atiera Kosenin, Muhammad Najmi Budiman Naim, Rafiqah Farhanah Redzuan, Nur Iffah Ab Rani, Najiha Arrissa Norhisham, Wahinuddin Sulaiman","doi":"10.31138/mjr.050723.fla","DOIUrl":"https://doi.org/10.31138/mjr.050723.fla","url":null,"abstract":"Objective: The aim of this study was to establish the incidence of liver abnormalities in psoriatic arthritis patients and identify the factors that contributed to this condition.Methods: This is a longitudinal cohort study. Psoriatic arthritis (PsA) patients with liver enzymes abnormalities were identified. Our control group consisted of PsA patient from the same cohort who had no history of liver abnormalities. Factors associated with liver abnormalities were identified using univariate and multivariate analysis.Results: A total of 247 of PsA patients were included and out of those, 99 developed liver enzymes abnormalities. The mean age of the patients was 56 years old (±13.5) with 56.1% female and 39.4% Indian descendants. The univariate logistic regression demonstrated that disease duration of PsA (OR=1.06, 95% CI=1.01 - 1.10, p=0.012), diabetes mellitus (OR=2.16, 95% CI=1.26 - 3.70, 0.005) and non-alcoholic fatty liver disease (NAFLD) (OR=3.90, 95% CI = 1.44 - 10.53, p=0.007) were associated with abnormal liver function in PsA patients. No association was found with both conventional synthetic disease-modifying antirheumatic drugs or biologics.Conclusion: Liver enzymes abnormalities in PsA patients were linked to disease duration, diabetes mellitus and NAFLD. For these high-risk populations, vigilant monitoring of liver function tests is vital for early detection and intervention.","PeriodicalId":32816,"journal":{"name":"Mediterranean Journal of Rheumatology","volume":"35 2","pages":"234-240"},"PeriodicalIF":0.0,"publicationDate":"2023-08-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11350418/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142112732","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Sternoclavicular Joint Tubercular Abscess in a Patient with Spondyloarthritis on Tofacitinib: A Case Report. 一名服用托法替尼的脊柱关节炎患者的胸锁关节结核脓肿：病例报告。

Mediterranean Journal of Rheumatology Pub Date : 2023-08-27 eCollection Date: 2024-09-01 DOI: 10.31138/mjr.270823.sjt

B Sai Sunil, Prasanta Padhan, Debashis Maikap

引用次数: 0

Dehydroepiandrosterone (DHEA) Supplementation in Rheumatic Diseases: A Systematic Review. 脱氢表雄酮（DHEA）在类风湿性疾病中的补充：一项系统综述。

Mediterranean Journal of Rheumatology Pub Date : 2023-08-25 eCollection Date: 2023-09-01 DOI: 10.31138/mjr.20230825.dd

Thelma L Skare, Elizabeth Hauz, Jozélio Freire de Carvalho

{"title":"Dehydroepiandrosterone (DHEA) Supplementation in Rheumatic Diseases: A Systematic Review.","authors":"Thelma L Skare, Elizabeth Hauz, Jozélio Freire de Carvalho","doi":"10.31138/mjr.20230825.dd","DOIUrl":"10.31138/mjr.20230825.dd","url":null,"abstract":"Background: Dehydroepiandrosterone (DHEA) is an adrenal hormone used to treat rheumatic conditions such as systemic lupus erythematosus (SLE), Sjogren's syndrome (SS), rheumatoid arthritis (RA) with controversial results.Aim: To review the results of DHEA use in rheumatic diseases.Methods: PubMed, Scielo, Scopus, and Embase databases were systematically searched for articles on the treatment of rheumatic diseases with DHEA between 1966 and April 2023.Results: Twenty-one studies were identified: 13 in SLE, 5 in SS, 2 in RA, and 1 in fibromyalgia. DHEA use in SLE has shown a mild to moderate effect on disease activity, a positive effect on bone mineral density (BMD), and improved fatigue. The studies on SS showed a decrease in symptoms of dry mouth, but its performance did not differ from placebo in disease activity. In RA, a questionable effect on disease activity was noted. The only study on fibromyalgia failed to show any improvement. The drug was well tolerated; mild androgenic effects were the most common complaints.Conclusion: DHEA seems to have a place in SLE treatment, where it improves BMD and disease activity. The use in RA, SS, and FM is questionable.","PeriodicalId":32816,"journal":{"name":"Mediterranean Journal of Rheumatology","volume":"34 3","pages":"292-301"},"PeriodicalIF":0.0,"publicationDate":"2023-08-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10628885/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71522799","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Cachexia Prevalence in a Population of Moroccan Women with Rheumatoid Arthritis. 患有类风湿性关节炎的摩洛哥女性人群中的痛风患病率。

Mediterranean Journal of Rheumatology Pub Date : 2023-08-25 eCollection Date: 2023-12-01 DOI: 10.31138/mjr.250823.cpp

Hamza Toufik, Najlae El Ouardi, Mohamed Ahmed Ghassem, Julien H Djossou, Laila Taoubane, Abderrahim Majjad, Abdellah El Maghraoui, Ahmed Bezza

{"title":"Cachexia Prevalence in a Population of Moroccan Women with Rheumatoid Arthritis.","authors":"Hamza Toufik, Najlae El Ouardi, Mohamed Ahmed Ghassem, Julien H Djossou, Laila Taoubane, Abderrahim Majjad, Abdellah El Maghraoui, Ahmed Bezza","doi":"10.31138/mjr.250823.cpp","DOIUrl":"10.31138/mjr.250823.cpp","url":null,"abstract":"Objective: To assess body composition in women with rheumatoid arthritis (RA) compared to healthy controls, to calculate the prevalence of rheumatoid Cachexia (RC), and to identify the associated factors.Methods: We conducted a case-control study on 112 female patients with RA according to the 2010 American College of Rheumatology/European League Against Rheumatism classification criteria for RA; and 224 age-matched healthy women. Body composition (BC) and bone mineral density (BMD) scans were obtained using Dual-energy X-ray absorptiometry (DXA). RC was defined by a fat-free mass index (FFMI) below the 10th percentile and a fat mass index (FMI) above the 25th percentile compared with the control group. We conducted a comparison between RA patients and healthy controls then a multiple regression analysis was conducted where the dependant variable is the presence of RC.Results: RC prevalence was 42.85% while the mean body mass index (BMI) was the same in both groups. RA patients had a higher FM and lower FFM comparing to healthy controls. In our population, 78.60% of patients were on methotrexate and 12.50% on anti TNF therapy. Comparison between patients with and without RC showed that patients with RC have a higher proportion of erosive arthritis and of active disease. Regression logistic analysis showed that RC was significantly associated to erosive arthritis and active disease (OR at 33.31 (8.42-131.70) and 8.98 (1.64-49.20) respectively), independently of age, erythrocyte sedimentation rate, C-reactive protein, disease duration, steroid cumulative dose and biologic Disease-Modifying Anti-Rheumatic Drugs(bDMARDs) use.Conclusion: Our study showed that almost half of our RA patients have RC, even with a high BMI.","PeriodicalId":32816,"journal":{"name":"Mediterranean Journal of Rheumatology","volume":"34 4","pages":"506-512"},"PeriodicalIF":0.0,"publicationDate":"2023-08-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10815517/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139571463","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Anaerobic Spondylodiscitis caused by Parvimonas Micra in a Rheumatoid Arthritis Patient: Case Report and Review of the Literature. 类风湿性关节炎患者中由米克拉副杆菌引起的厌氧性脊椎盘炎：病例报告和文献综述。

Mediterranean Journal of Rheumatology Pub Date : 2023-08-24 eCollection Date: 2023-12-01 DOI: 10.31138/mjr.240823.asc

Panagiotis Kalmoukos, Dimitrios Kouroupis, Georgios Sapouridis, Elisavet Simoulidou, Anna Varouktsi, Charalampos Zarras, Konstantinos Petidis, Athina Pyrpasopoulou

引用次数: 0

Penicillamine-Induced Localised Cutis Laxa in a Patient with Wilson Disease: A Case Report. 威尔逊病患者青霉胺诱发的局部皮肤松弛症：病例报告。

Mediterranean Journal of Rheumatology Pub Date : 2023-08-23 eCollection Date: 2024-03-01 DOI: 10.31138/mjr.280223.pil

Eleni Routsi, Antonios Kanelleas, Vassileios Papaefthymiou, Georgia Pappa, Alexandros Katoulis

{"title":"Penicillamine-Induced Localised Cutis Laxa in a Patient with Wilson Disease: A Case Report.","authors":"Eleni Routsi, Antonios Kanelleas, Vassileios Papaefthymiou, Georgia Pappa, Alexandros Katoulis","doi":"10.31138/mjr.280223.pil","DOIUrl":"10.31138/mjr.280223.pil","url":null,"abstract":"Introduction: Wilson disease is a rare genetic disorder, characterised by excessive deposition of copper in the liver, brain, and other tissues. Penicillamine, a copper-chelating agent, is used in high doses in the treatment of Wilson disease leading to a variety of cutaneous reactions, including hyper-sensitivity reactions, pseudoxanthoma elasticum, elastosis perforans serpiginosa, anetoderma, and cutis laxa (CL). We present a rare case of localised CL induced by penicillamine for Wilson disease, in the absence of elastosis perforans serpiginosa.Case description: A 41-year-old male with Wilson disease treated with long-term high-dose penicillamine was referred to us for a basal cell carcinoma on the scalp. On physical examination, diffusely flaccid and redundant skin on the right side of the neck were observed. Histopathology revealed findings consistent with CL.Conclusion: Long-term treatment with penicillamine for Wilson disease may induce localized CL, possibly by direct inhibition of cross-linkage of collagen fibres.","PeriodicalId":32816,"journal":{"name":"Mediterranean Journal of Rheumatology","volume":"35 1","pages":"184-186"},"PeriodicalIF":0.0,"publicationDate":"2023-08-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11082779/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140912954","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

An Oral Form of Cetylated Fatty Acids versus Meloxicam for Knee Osteoarthritis: A Randomised Clinical Trial. 治疗膝关节骨关节炎的十六烷基化脂肪酸口服制剂与美洛昔康的比较：随机临床试验

Mediterranean Journal of Rheumatology Pub Date : 2023-08-22 eCollection Date: 2023-12-01 DOI: 10.31138/mjr.220823.aof

Sepide Mohebi, Hamid Reza Farpour, Kayvon Seyed Dehghanian, Sana Sadat Khoshnazar

{"title":"An Oral Form of Cetylated Fatty Acids versus Meloxicam for Knee Osteoarthritis: A Randomised Clinical Trial.","authors":"Sepide Mohebi, Hamid Reza Farpour, Kayvon Seyed Dehghanian, Sana Sadat Khoshnazar","doi":"10.31138/mjr.220823.aof","DOIUrl":"10.31138/mjr.220823.aof","url":null,"abstract":"Objective/aim: This study aimed to assess how effective an oral form of Cetylated fatty acids compounds (CFA) is in improving the physical function, pain, and stiffness of individuals suffering from knee osteoarthritis (OA) and how its effectiveness compares to that of Meloxicam, a non-steroidal anti-inflammatory drug (NSAID).Methods: For this parallel-arm randomised clinical trial, 48 adult patients with knee OA were divided into two groups. The intervention group was prescribed 350mg CFA capsule three times per day for 30 days. The control group was given 15mg of Meloxicam, one tablet daily for ten days. Patients were instructed to fill out the Oxford Knee Score (OKS), Western Ontario and McMaster University Osteoarthritis Index (WOMAC), and Visual Analog Scale (VAS). Data were obtained before the administration of the first dose (considered baseline or t0), and two (t1), four (t2), and eight (t3) weeks after the final dose of each intervention.Results: No significant differences were observed in total WOMAC and OKS scores between the two groups at t1, t2, or t3. However, both groups had significant improvements in their OKS, VAS, and total WOMAC scores compared to their baselines (t0). No adverse events were noted in the CFA group.Conclusion: Improvements in pain intensity and overall physical function were reported in the CFA group. Oral CFAs could safely benefit patients with knee OA.","PeriodicalId":32816,"journal":{"name":"Mediterranean Journal of Rheumatology","volume":"34 4","pages":"460-468"},"PeriodicalIF":0.0,"publicationDate":"2023-08-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10815532/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139571461","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Quality-of-Life Endpoints in Women of Childbearing Age with Hidradenitis Suppurativa: A Tertiary-Care-Centre-Based Study. 患有化脓性扁平湿疹的育龄妇女的生活质量终点：一项基于三级医疗中心的研究

Mediterranean Journal of Rheumatology Pub Date : 2023-08-22 eCollection Date: 2023-12-01 DOI: 10.31138/mjr.220823.qoe

Aikaterini Tsentemeidou, Elena Sotiriou, Katerina Bakirtzi, Ilias Papadimitriou, Themis Chatzi-Sotiriou, Angeliki Panagopoulou, Nikolaos Kougkas, Aimilios Lallas, Efstratios Vakirlis

{"title":"Quality-of-Life Endpoints in Women of Childbearing Age with Hidradenitis Suppurativa: A Tertiary-Care-Centre-Based Study.","authors":"Aikaterini Tsentemeidou, Elena Sotiriou, Katerina Bakirtzi, Ilias Papadimitriou, Themis Chatzi-Sotiriou, Angeliki Panagopoulou, Nikolaos Kougkas, Aimilios Lallas, Efstratios Vakirlis","doi":"10.31138/mjr.220823.qoe","DOIUrl":"10.31138/mjr.220823.qoe","url":null,"abstract":"Background: Hidradenitis suppurativa (HS) principally affects women of childbearing age, who face gender-specific challenges and have lower life-quality than men. HS also seems to impact desire for procreation.Objective: To investigate various quality-of-life endpoints in women of childbearing age with HS.Study design: A cross-sectional questionnaire-based study was performed at a university dermatology department. Eighteen yes/no and one open-ended questions explored impact of HS on social life, sexual life, family planning, working life and healthcare-backed support. A sensitivity analysis was performed for women under 25, who are significantly less likely to be married/in a permanent relationship in Greece, as this could act as a confounding factor regarding family planning.Results: Ninety-six women were included. Most women (80.8%) carry a stigma because of HS, which also affects their choice of clothes and social relationships. Sexual impairment affects 73.1% of women. One third of women wants less or no children because of HS, 67.7% worry about its impact on pregnancy, birth, and the postpartum, and 84.6% worry about the impact of HS treatment on fertility and their babies' health. Almost 43% fear losing their job because of HS, 34.4% are discriminated against at work and 33.3% state HS has hindered their career. Most women are not adequately informed about their disease or available support groups/material and 41.7% have not received good enough care through pregnancy/postpartum.Conclusions: Life-quality endpoints should be meticulously screened in women. Multidisciplinary-led treatment should be offered during pregnancy and the postpartum.","PeriodicalId":32816,"journal":{"name":"Mediterranean Journal of Rheumatology","volume":"34 4","pages":"469-478"},"PeriodicalIF":0.0,"publicationDate":"2023-08-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10815518/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139571566","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0